Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Alexandria Venture Investments

Profile and portfolio

Parent Alexandria Real Estate EquitiesHQ Pasadena, United StatesFounded 1996

Alexandria Venture Investments is the corporate venture arm of Alexandria Real Estate Equities, a real estate and construction company. It was founded in 1996 and is based in Pasadena, United States. It invests from seed to growth. Sectors it names: biotech and life sciences, healthcare and digital health, food and agriculture.

Every figure links to its source

Snapshot

Investment stage: Seed to Growth
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Growth
SectorsBiotech and life sciences, Healthcare and digital health, Food and agriculture
GeographyGlobal
OfficesPasadena, United States

Sources: S2 PharmaShots: Know your investor, Alexandria Venture (May 2025); S1 Alexandria Real Estate Equities: Alexandria Venture Investments ranked #1 most active corporate investor in biopharma.

Graphic 1 of 1

Investment stage: Seed to Growth

Sources: S2 PharmaShots: Know your investor, Alexandria Venture (May 2025); S1 Alexandria Real Estate Equities: Alexandria Venture Investments ranked #1 most active corporate investor in biopharma.

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
Pasadena, United States
Offices
  • Pasadena, United States

Investment regionsS2S1

LeadersS3

  • Joel S. MarcusExecutive Chairman & Founder, Alexandria Real Estate EquitiesFind on LinkedInFirm page
  • Hallie E. KuhnExecutive Vice President, Capital Markets & Co-Lead, Life Science, Alexandria Real Estate Equities and Alexandria Venture InvestmentsFind on LinkedInFirm page
  • Jenna FogerExecutive Vice President, Co-Lead, Life Science, Alexandria Real Estate Equities and Alexandria Venture InvestmentsFind on LinkedInFirm page

Alexandria Venture Investments on LinkedIn

Key facts

FactValueStatusSource
Parent companyAlexandria Real Estate Equities (NYSE: ARE)Single sourceS1
Parent industryReal estate and constructionSingle sourceS1
Founded1996Single sourceS3
HeadquartersPasadena, United StatesSingle sourceS4
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
StagesSeed, Series A, Growth (inferred from announced rounds)EstimateS2

About Alexandria Real Estate Equities

ItemDetailSource
Listed asNYSE: ARES1
HeadquartersUnited StatesS1

Portfolio

Public sources name 9 portfolio companies.S2

Shared portfolio with other corporate VCs

5 companies on the Alexandria Venture Investments portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
GV2Grail, Relay Therapeutics
Leaps by Bayer1Capstan Therapeutics
Pfizer Ventures1Capstan Therapeutics
Dentsu Ventures1Grail
Sanofi Ventures1Mirador Therapeutics
NVentures1Terray Therapeutics

Companies backed by the most corporate VCs

Every company on the Alexandria Venture Investments list

9 companies, as named in the sources cited.S2 Read the firm's list.

  • Alnylam
  • Capstan Therapeutics
  • GRAIL
  • Intra-Cellular Therapies
  • Judo Bio
  • Mirador Therapeutics
  • Moderna
  • Relay Therapeutics
  • Terray Therapeutics

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Alexandria Real Estate Equities: Alexandria Venture Investments ranked #1 most active corporate investor in biopharmaFirm
  2. S2PharmaShots: Know your investor, Alexandria Venture (May 2025)Press
  3. S3Alexandria Meet Our Team (executive bios, venture platform leaders)Firm
  4. S4Alexandria Contact Us (Pasadena principal office)Firm

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Alexandria Venture Investments or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.